WUP0.F Sanai Health Industry Group Company Limited
- Market cap
- EUR 2.45M
- P/E
- 1.6x
- P/B
- 0.11x
- ROE
- -7.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is WUP0.F undervalued?
Graham numberThe Graham number of Sanai Health Industry Group Company Limited cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sanai Health Industry Group Company Limited fundamental analysis
No fundamental analysis for Sanai Health Industry Group Company Limited yet.
Sanai Health Industry Group Company Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sanai Health Industry Group Company Limited
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People's Republic of China and Hong Kong. It operates through Pharmaceutical Products and Finance Leasing segments. The company is involved in development, manufacturing, marketing, and sales of pharmaceutical products; sale of pharmaceutical related software;…
Full company profileSanai Health Industry Group Company Limited financial statements
Sanai Health Industry Group Company Limited annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 67.6M | 176M | 108M | 85.2M | 85.9M |
| Gross Profit | 40.6M | 91.7M | 29.2M | 16.9M | 14.3M |
| Operating Income | 25.7M | 61.4M | 18.4M | -11.2M | -22.7M |
| EBITDA | - | 61.1M | 25.5M | -7.59M | -20.2M |
| Net Income | 9.03M | 29.2M | 18.6M | 4.89M | -22.0M |
| EPS | 0.07 | 0.23 | 0.15 | 0.03 | -0.14 |
| Balance Sheet | |||||
| Total Assets | 311M | 385M | 383M | 469M | 422M |
| Total Liabilities | 91.7M | 129M | 114M | 117M | 97.6M |
| Shareholders' Equity | 199M | 246M | 264M | 322M | 298M |
| Cash & Short-term Investments | 16.3M | 21.8M | 332M | 340M | 299M |
| Cash Flow | |||||
| Operating Cash Flow | -38.7M | -56.2M | 321M | 11.8M | -53.2M |
| Capital Expenditure | 73.0K | 27.0K | 82.0K | 1.17M | 1.13M |
| Free Cash Flow | -38.8M | -56.2M | 321M | 10.6M | -54.4M |
| Ratios | |||||
| ROE | 4.5% | 11.9% | 7.0% | 1.5% | -7.4% |
| ROA | 2.9% | 7.6% | 4.9% | 1.0% | -5.2% |
| Net Profit Margin | 13.3% | 16.6% | 17.3% | 5.7% | -25.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Sanai Health Industry Group Company Limited dividends
Sanai Health Industry Group Company Limited has not paid dividends in the last 8 fiscal years.
Last stock split: 1:25 on Aug 13, 2024.
Who owns Sanai Health Industry Group Company Limited
- Insiders 35.89%
- Institutions 0.00%
- Public & others 64.11%
- Shares outstanding 153M
- Free float 104M
Sanai Health Industry Group Company Limited company profile
- Company name
- Sanai Health Industry Group Company Limited
- Ticker
- WUP0.F
- ISIN
- KYG7785S1158
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 140
- Fiscal year end
- December
- Address
- Nanyang Plaza, Kwun Tong, Hong Kong
- Phone
- 852 2827 6100
- Website
- 1889hk.com
About Sanai Health Industry Group Company Limited
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People's Republic of China and Hong Kong. It operates through Pharmaceutical Products and Finance Leasing segments. The company is involved in development, manufacturing, marketing, and sales of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services. It also provides finance leasing services; and engages in the research, production, and sale of health products, functional foods, and skincare products in the field of soft capsule dosage form. Sanai Health Industry Group Company Limited was incorporated in 2006 and is based in Kwun Tong, Hong Kong.
Sanai Health Industry Group Company Limited management
3- Mr. Chaoyang YuanExecutive Director · born 1973
- Mr. Haijing XieExecutive Director · born 1972
- Ms. Yuen Fong ChanCompany Secretary